ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Clinical trial NCT01777152 · COMPLETED

Trial details

NCT number

NCT01777152

Sponsor

Seagen Inc.

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2013-01-31

Primary completion

2018-08-15

Enrollment

452

View on ClinicalTrials.gov